Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters
Monoamine transporters, including dopamine, norepinephrine, and serotonin transporters (DAT, NET, and SERT, respectively), are important therapeutic targets due to their essential roles in the brain. To overcome the slow action of selective monoamine reuptake inhibitors, dual- or triple-acting inhib...
Main Authors: | Hyomin Ahn, Kichul Park, Dongyoung Kim, Sung-Gil Chi, Kee-Hyun Choi, Seo-Jung Han, Chiman Song |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/10/2846 |
Similar Items
-
Monoamine transporters: Insights from molecular dynamics simulations
by: Julie eGrouleff, et al.
Published: (2015-10-01) -
Designing Modulators of Monoamine Transporters using Virtual Screening Techniques
by: Ole Valente Mortensen, et al.
Published: (2015-09-01) -
Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions
by: Malik Alwindi, et al.
Published: (2023-11-01) -
Colorimetric dopamine detection based on immobilized monoamine oxidase through silver nanoparticles
by: Shin, Gounhanul, et al.
Published: (2023) -
Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry
by: Predrag Kalaba, et al.
Published: (2023-09-01)